Opportunity Information: Apply for PAR 13 090
Apply for PAR 13 090
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.837 Cardiovascular Diseases Research 93.838 Lung Diseases Research 93.839 Blood Diseases and Resources Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Jan 23, 2013 and posted on Jan 23, 2013.
- Applicants must submit their applications by May 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (R43/R44)" (Funding Opportunity Number PAR 13-090) was a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) solicitation administered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Its central purpose was to spur small business-led research and development aimed at creating new medical devices and clinical instruments, or meaningfully improving existing ones, specifically for use with newborn infants and young children. The emphasis throughout the announcement is on practical innovation that makes monitoring and treatment in neonatal and pediatric care safer and more effective, reflecting the reality that devices designed for adults often do not translate well to very small, fragile, or rapidly developing patients.
This opportunity used the SBIR phased award structure associated with the R43 and R44 mechanisms. In plain terms, it supported early-stage proof-of-concept and feasibility work (typically aligned with Phase I) and, for projects that demonstrated strong promise, further development and refinement (typically aligned with Phase II). The goal was to move technologies along a pipeline from concept to a more mature, validated product direction that could ultimately be used in real clinical environments such as neonatal intensive care units (NICUs), pediatric inpatient units, specialty clinics, and related care settings. While the short description does not list specific topic areas, the scope is broad enough to cover devices and instruments used for monitoring physiologic status, diagnosing conditions, delivering therapies, or otherwise improving care processes for neonates and pediatric patients, as long as the work is clearly focused on safety, efficacy, and appropriateness for these age groups.
Eligibility was limited to small business concerns, which is consistent with the SBIR program's intent to translate biomedical innovation through U.S. small businesses. The award type was a discretionary grant, and there was no cost sharing or matching requirement stated in the summary information, meaning applicants were not required to contribute a specific percentage of project costs as a condition of receiving funds. The opportunity was posted and created on January 23, 2013, with an original and final closing date of May 7, 2016, and it was archived on June 7, 2016, indicating it is no longer open for new applications under that specific announcement.
In terms of the broader research landscape, the opportunity is associated with multiple CFDA program areas spanning child health and development and several disease and research domains (including cardiovascular, lung, blood, neuroscience/neurological disorders, and mental health research grant categories). That mix signals that NICHD anticipated device and instrument concepts could touch many clinical problems encountered in neonatal and pediatric care, from respiratory support and hemodynamic monitoring to neurologic assessment and other specialized needs. Applicants would have been expected to propose a development plan grounded in pediatric and neonatal clinical realities, such as size constraints, skin fragility, reduced blood volume, developmental differences in anatomy and physiology, and the need to minimize invasiveness and risk while still obtaining reliable measurements or delivering therapies effectively.
For applicants seeking the full official requirements, the announcement directed readers to the NIH Grants Guide posting at the provided link, and it listed the NIH Office of Extramural Research (OER) webmaster contacts for technical difficulties accessing or linking to the announcement.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (R43/R44)" and the Funding Opportunity Number is PAR 13-090.
Which agency and institute offered this funding opportunity?
This was a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) solicitation administered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
What was the main purpose of the opportunity?
The central purpose was to spur small business-led research and development to create new medical devices and clinical instruments, or meaningfully improve existing ones, specifically for use with newborn infants and young children. The emphasis was on practical innovation that makes neonatal and pediatric monitoring and treatment safer and more effective.
What types of projects were in scope?
The scope was broadly focused on devices and instruments used in neonatal and pediatric care, including concepts related to monitoring physiologic status, diagnosing conditions, delivering therapies, or improving care processes, as long as the work clearly addressed safety, efficacy, and age-appropriate use for neonates and pediatric patients.
What care settings were intended for the resulting technologies?
The announcement emphasized real clinical environments such as neonatal intensive care units (NICUs), pediatric inpatient units, specialty clinics, and related neonatal and pediatric care settings.
Why was there a special focus on neonatal and pediatric devices rather than adapting adult devices?
The opportunity highlighted that devices designed for adults often do not translate well to very small, fragile, or rapidly developing patients. Proposed innovations were expected to reflect pediatric and neonatal clinical realities and reduce risk while maintaining reliable performance.
What award mechanisms were used (R43 and R44)?
This solicitation used the SBIR phased award structure associated with the R43 and R44 mechanisms. In practical terms, it supported early-stage proof-of-concept and feasibility work (typically aligned with Phase I) and, for projects showing strong promise, further development and refinement (typically aligned with Phase II).
How did the phased SBIR structure relate to technology maturity?
The goal was to move technologies along a pipeline from concept to a more mature and validated product direction that could ultimately be used in real neonatal and pediatric clinical environments.
Who was eligible to apply?
Eligibility was limited to small business concerns, consistent with the SBIR program's intent to translate biomedical innovation through U.S. small businesses.
What type of funding instrument was this?
The award type was a discretionary grant.
Was cost sharing or matching required?
No cost sharing or matching requirement was stated in the summary information. Applicants were not required to contribute a specific percentage of project costs as a condition of receiving funds.
When was the opportunity posted, and what were the closing dates?
The opportunity was posted and created on January 23, 2013. The original and final closing date was May 7, 2016.
Is this funding opportunity still open?
No. The opportunity was archived on June 7, 2016, which indicates it is no longer open for new applications under that specific announcement.
What clinical or scientific areas could the proposed devices relate to?
The opportunity was associated with multiple CFDA program areas spanning child health and development and several disease and research domains, including cardiovascular, lung, blood, neuroscience/neurological disorders, and mental health research grant categories. This signaled that proposed devices could address many clinical problems encountered in neonatal and pediatric care.
What pediatric and neonatal design realities were applicants expected to account for?
Applicants were expected to ground their development plans in pediatric and neonatal clinical realities such as size constraints, skin fragility, reduced blood volume, developmental differences in anatomy and physiology, and the need to minimize invasiveness and risk while still obtaining reliable measurements or delivering therapies effectively.
Did the summary list specific topic areas?
No specific topic areas were listed in the short description, but the scope was described as broad enough to cover a wide range of neonatal and pediatric monitoring, diagnostic, therapeutic, and care-process technologies.
Where were applicants directed to find the official requirements?
For the full official requirements, the announcement directed readers to the NIH Grants Guide posting at the provided link.
Who was listed for technical help accessing the announcement?
The opportunity listed the NIH Office of Extramural Research (OER) webmaster contacts for technical difficulties accessing or linking to the announcement.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Centers of Research Excellence in Science and Technology
Previous opportunity: SMART FY 13 Support for Adam Walsh Implementation Grant Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 090
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 090) also looked into and applied for these:
| Funding Opportunity |
|---|
| Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (R41/R42) Apply for PAR 13 091 Funding Number: PAR 13 091 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Differentiation and Integration of Stem Cells (Embryonic and Induced Pluripotent) Into Developing or Damaged Tissues (R21) Apply for PAR 13 095 Funding Number: PAR 13 095 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Differentiation and Integration of Stem Cells (Embryonic and Induced Pluripotent) Into Developing or Damaged Tissues (R01) Apply for PAR 13 094 Funding Number: PAR 13 094 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $500,000 |
| Evaluation of the Latent Reservoir in HIV Infected Infants and Children with Early Antiretroviral Treatment and Virologic Control (R01) Apply for RFA HD 14 026 Funding Number: RFA HD 14 026 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $750,000 |
| Team Based Design in Biomedical Engineering Education (R25) Apply for PAR 13 111 Funding Number: PAR 13 111 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Postdoctoral Training Program in Obstetric and Pediatric Pharmacoepidemiology (T32) Apply for PAR 13 112 Funding Number: PAR 13 112 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Safety and Effectiveness of Triple Antiretroviral Drug Strategies for Prevention of Mother to Child HIV Transmission (R01) Apply for RFA HD 14 027 Funding Number: RFA HD 14 027 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54) Apply for RFA HD 14 017 Funding Number: RFA HD 14 017 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Orthotics for Pediatric Populations (SBIR) (R43) Apply for RFA HD 14 029 Funding Number: RFA HD 14 029 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $225,000 |
| Orthotics for Healthy Development (STTR) (R41) Apply for RFA HD 14 028 Funding Number: RFA HD 14 028 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Mucosal Environment and HIV Prevention (MEHP) (R01) Apply for RFA AI 13 012 Funding Number: RFA AI 13 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $400,000 |
| Male Contraceptive Development Program (U01) Apply for RFA HD 14 023 Funding Number: RFA HD 14 023 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Methods Development for Obtaining Comprehensive Genomic Information from Human Specimens that are Easy to Collect and Store (R43/R44) Apply for PAR 13 203 Funding Number: PAR 13 203 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Dual Purpose with Dual Benefit Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01) Apply for PAR 13 204 Funding Number: PAR 13 204 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Biophysical and Biomechanical Aspects of Embryonic Development (R21) Apply for PAR 13 206 Funding Number: PAR 13 206 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Biophysical and Biomechanical Aspects of Embryonic Development (R01) Apply for PAR 13 207 Funding Number: PAR 13 207 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $500,000 |
| Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01) Apply for PAR 13 213 Funding Number: PAR 13 213 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) Apply for PAR 13 195 Funding Number: PAR 13 195 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $499,999 |
| Pediatric Critical Care and Trauma Scientist Development Program (K12) Apply for RFA HD 14 019 Funding Number: RFA HD 14 019 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $720,037 |
| In vivo Methods for Assessing Placental Development and Function (SBIR) (R43/R44) Apply for RFA HD 14 005 Funding Number: RFA HD 14 005 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 090", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.